Suppr超能文献

客户和咨询师对使用药物治疗阿片类药物依赖的态度。

Client and counselor attitudes toward the use of medications for treatment of opioid dependence.

作者信息

Rieckmann Traci, Daley Marilyn, Fuller Bret E, Thomas Cindy P, McCarty Dennis

机构信息

Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR 97239, USA.

出版信息

J Subst Abuse Treat. 2007 Mar;32(2):207-15. doi: 10.1016/j.jsat.2006.09.002. Epub 2006 Dec 8.

Abstract

Attitudes, perceived social norms, and intentions were assessed for 376 counselors and 1,083 clients from outpatient, methadone, and residential drug treatment programs regarding four medications used to treat opiate dependence: methadone, buprenorphine, clonidine, and ibogaine. Attitudes, social norms, and intentions to use varied by treatment modality. Methadone clients and counselors had more positive attitudes toward the use of methadone, whereas their counterparts in residential and outpatient settings had neutral or negative assessments. Across modalities, attitudes, perceived social norms, and intentions toward the use of buprenorphine were relatively neutral. Assessments of clonidine and ibogaine were negative for clients and counselors in all settings. Social normative influences were dominant across settings and medications in determining counselor and client intentions to use medications, suggesting that perceptions about beliefs of peers may play a critical role in use of medications to treat opiate dependence.

摘要

针对来自门诊、美沙酮和住院戒毒治疗项目的376名咨询师和1083名客户,评估了他们对用于治疗阿片类药物依赖的四种药物的态度、感知到的社会规范和意图,这四种药物分别是美沙酮、丁丙诺啡、可乐定和伊博格碱。态度、社会规范和使用意图因治疗方式而异。美沙酮客户和咨询师对使用美沙酮的态度更为积极,而住院和门诊环境中的客户和咨询师则持中性或负面评价。在所有治疗方式中,对丁丙诺啡使用的态度、感知到的社会规范和意图相对中性。在所有环境中,客户和咨询师对可乐定和伊博格碱的评价都是负面的。在决定咨询师和客户使用药物的意图方面,社会规范影响在所有环境和药物中都占主导地位,这表明对同伴信念的认知可能在使用药物治疗阿片类药物依赖中起关键作用。

相似文献

1
Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
J Subst Abuse Treat. 2007 Mar;32(2):207-15. doi: 10.1016/j.jsat.2006.09.002. Epub 2006 Dec 8.
2
Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
J Clin Psychopharmacol. 1996 Feb;16(1):58-67. doi: 10.1097/00004714-199602000-00010.
4
Buprenorphine for acute heroin detoxification: diffusion of research into practice.
J Subst Abuse Treat. 2007 Mar;32(2):199-206. doi: 10.1016/j.jsat.2006.08.003. Epub 2006 Nov 21.
5
A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.
J Subst Abuse Treat. 2011 Dec;41(4):374-85. doi: 10.1016/j.jsat.2011.05.005. Epub 2011 Aug 6.
6
Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
Drug Alcohol Depend. 1995 Oct;39(3):207-12. doi: 10.1016/0376-8716(95)01159-8.
7
A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.
Addiction. 2002 Nov;97(11):1395-404. doi: 10.1046/j.1360-0443.2002.00215.x.
10
Heroin anticraving medications: a systematic review.
Am J Drug Alcohol Abuse. 2010 Nov;36(6):332-41. doi: 10.3109/00952990.2010.505991. Epub 2010 Oct 19.

引用本文的文献

1
Patient perspectives on medications for alcohol use disorder: A systematic scoping review.
Alcohol Clin Exp Res (Hoboken). 2025 Apr;49(4):725-735. doi: 10.1111/acer.70022. Epub 2025 Mar 11.
2
Opioid treatment program culture and philosophy: Views of OTP staff and state officials on implementing interim methadone treatment.
J Subst Use Addict Treat. 2024 Feb;157:209265. doi: 10.1016/j.josat.2023.209265. Epub 2023 Dec 14.
4
Qualitative characterizations of misinformed disclosure reactions to medications for opioid use disorders and their consequences.
J Subst Abuse Treat. 2022 Jan;132:108593. doi: 10.1016/j.jsat.2021.108593. Epub 2021 Aug 9.
5
Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.
J Subst Abuse Treat. 2021 Dec;131:108464. doi: 10.1016/j.jsat.2021.108464. Epub 2021 May 8.
6
Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.
J Subst Abuse Treat. 2021 Apr;123:108247. doi: 10.1016/j.jsat.2020.108247. Epub 2020 Dec 11.
7
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.
J Subst Abuse Treat. 2020 Dec;119:108146. doi: 10.1016/j.jsat.2020.108146. Epub 2020 Sep 22.
8
Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.
Am J Drug Alcohol Abuse. 2020 May 3;46(3):266-272. doi: 10.1080/00952990.2020.1719410. Epub 2020 Feb 24.
10
Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results.
J Subst Abuse Treat. 2020 Jan;108:115-122. doi: 10.1016/j.jsat.2019.08.006. Epub 2019 Oct 24.

本文引用的文献

1
Buprenorphine for acute heroin detoxification: diffusion of research into practice.
J Subst Abuse Treat. 2007 Mar;32(2):199-206. doi: 10.1016/j.jsat.2006.08.003. Epub 2006 Nov 21.
5
Staff beliefs about addiction treatment.
J Subst Abuse Treat. 2001 Jul;21(1):1-9. doi: 10.1016/s0740-5472(01)00173-8.
6
Effects of managed care on programs and practices for the treatment of alcohol and drug dependence.
Recent Dev Alcohol. 2001;15:51-71. doi: 10.1007/978-0-306-47193-3_4.
7
Drug therapy for alcohol dependence.
N Engl J Med. 1999 May 13;340(19):1482-90. doi: 10.1056/NEJM199905133401907.
8
Pharmacological treatment of alcohol dependence: a review of the evidence.
JAMA. 1999 Apr 14;281(14):1318-25. doi: 10.1001/jama.281.14.1318.
9
The theory of planned behavior: a review of its applications to health-related behaviors.
Am J Health Promot. 1996 Nov-Dec;11(2):87-98. doi: 10.4278/0890-1171-11.2.87.
10
Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings.
J Subst Abuse Treat. 1999 Mar;16(2):105-12. doi: 10.1016/s0740-5472(98)00028-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验